CHMP recommends EU conditional approval of Roche’s antibody Mosunetuzumab for people with relapsed Follicular Lymphoma Read more
IIT Madras-designed trial shows efficacy of Indomethacin drug in treating hospitalised mild and moderate COVID-19 patients Read more